Abstract:Our aim was to compare bronchial responses to major cat allergen (Fel d 1) in individuals with intermittent asthma sensitized to cats (19 subjects) according to the droplet particle size. We used three nebulizers, which delivered particles with mass median aerodynamic diameters of 1.4, 4.8, and 10.3 microm. A dosimeter nebulizer was used. The cat allergen was diluted to obtain the same amount of Fel d 1 per puff with each nebulizer. Each patient underwent three methacholine bronchial challenge tests (BCT), eac… Show more
“…Subjects sensitized to small particles were more likely to have higher airway responsiveness compared with subjects sensitized only to large particles. That contradicts results of previous studies where larger aerosols of adenosine monophosphate ( 41 ), methacholine ( 14 ), cat allergen ( 42 ), and mite allergen ( 43 ) gave more immediate responses than smaller particles. The same quantity could be delivered in both large and small airways with the nebulizer, but the concentration relative to the area of deposition in the larger airways would be higher as deposition of the same dose in the small airways could be insufficient to achieve similar airway bronchoconstriction due to the larger area of the small airways.…”
Section: Discussioncontrasting
confidence: 90%
“…To our knowledge, few studies ( 14 , 41 – 43 ) examined the effects of IgE sensitization with regard to particle size on the airways responsiveness, lung function, and markers of systemic inflammation during bronchial challenge tests. Differential immediate and late allergic responses were reported in relation to particle size with small allergen particles leading to significantly lower FEF 25–75 at 24 h after provocation compared with large particles ( 42 ). Our study demonstrated a differential response to smaller allergen particles (for example cat and dog) leading to an increase of F E NO 50 , mainly explained by an increase in airway concentration of NO but no effect on alveolar contribution to NO.…”
BackgroundThe size of inhaled particles influences where they deposit and theoretically should be important for the development of airway inflammation and responsiveness. Our aim was to assess if sensitization to smaller-sized aeroallergens relates to higher prevalence of treated asthma, increased airway responsiveness, and airway and systemic inflammation.MethodsMolecular-based IgE antibody determination was done in 467 subjects. Sensitized subjects were grouped based on the particle size of the aeroallergen: (1) Large particles only (mainly pollen); (2) Medium-sized particles (sensitized to mainly mite and mold and possibly to large particles); and 3) Small particles (sensitized to pet allergens and possibly to medium- and/or large-sized particles). Airway responsiveness to methacholine, exhaled nitric oxide (FENO), and serum eosinophil cationic protein (S-ECP) were measured. Asthma and rhinitis were questionnaire-assessed.ResultsSubjects sensitized to small particles had higher prevalence of treated asthma (35% versus 10%, P < 0.001), higher FENO50 (32 versus 17 ppb, P < 0.001), higher S-ECP (10 versus 7.5 ng/mL, P = 0.04), and increased bronchial responsiveness (dose-response slope, 5.6 versus 7.5, P < 0.001) compared with non-atopics. This was consistent after adjusting for potential confounders. Sensitization to only large or to medium and possibly also large aeroallergen particles was not related to any of these outcomes after adjustments.ConclusionsSensitization to smaller particles was associated with a higher prevalence of asthma under treatment, higher airway responsiveness, and airway and systemic inflammation. Mapping of IgE sensitization to small particles might help to detect subjects having increased airway and systemic inflammation and bronchial responsiveness, indicating increased risk of developing asthma.
“…Subjects sensitized to small particles were more likely to have higher airway responsiveness compared with subjects sensitized only to large particles. That contradicts results of previous studies where larger aerosols of adenosine monophosphate ( 41 ), methacholine ( 14 ), cat allergen ( 42 ), and mite allergen ( 43 ) gave more immediate responses than smaller particles. The same quantity could be delivered in both large and small airways with the nebulizer, but the concentration relative to the area of deposition in the larger airways would be higher as deposition of the same dose in the small airways could be insufficient to achieve similar airway bronchoconstriction due to the larger area of the small airways.…”
Section: Discussioncontrasting
confidence: 90%
“…To our knowledge, few studies ( 14 , 41 – 43 ) examined the effects of IgE sensitization with regard to particle size on the airways responsiveness, lung function, and markers of systemic inflammation during bronchial challenge tests. Differential immediate and late allergic responses were reported in relation to particle size with small allergen particles leading to significantly lower FEF 25–75 at 24 h after provocation compared with large particles ( 42 ). Our study demonstrated a differential response to smaller allergen particles (for example cat and dog) leading to an increase of F E NO 50 , mainly explained by an increase in airway concentration of NO but no effect on alveolar contribution to NO.…”
BackgroundThe size of inhaled particles influences where they deposit and theoretically should be important for the development of airway inflammation and responsiveness. Our aim was to assess if sensitization to smaller-sized aeroallergens relates to higher prevalence of treated asthma, increased airway responsiveness, and airway and systemic inflammation.MethodsMolecular-based IgE antibody determination was done in 467 subjects. Sensitized subjects were grouped based on the particle size of the aeroallergen: (1) Large particles only (mainly pollen); (2) Medium-sized particles (sensitized to mainly mite and mold and possibly to large particles); and 3) Small particles (sensitized to pet allergens and possibly to medium- and/or large-sized particles). Airway responsiveness to methacholine, exhaled nitric oxide (FENO), and serum eosinophil cationic protein (S-ECP) were measured. Asthma and rhinitis were questionnaire-assessed.ResultsSubjects sensitized to small particles had higher prevalence of treated asthma (35% versus 10%, P < 0.001), higher FENO50 (32 versus 17 ppb, P < 0.001), higher S-ECP (10 versus 7.5 ng/mL, P = 0.04), and increased bronchial responsiveness (dose-response slope, 5.6 versus 7.5, P < 0.001) compared with non-atopics. This was consistent after adjusting for potential confounders. Sensitization to only large or to medium and possibly also large aeroallergen particles was not related to any of these outcomes after adjustments.ConclusionsSensitization to smaller particles was associated with a higher prevalence of asthma under treatment, higher airway responsiveness, and airway and systemic inflammation. Mapping of IgE sensitization to small particles might help to detect subjects having increased airway and systemic inflammation and bronchial responsiveness, indicating increased risk of developing asthma.
“…The immediate bronchial response to Fel d 1 appears to be located in the proximal airways. The concentration of Fel d 1 required to induce a positive bronchial response in subjects with intermittent asthma was 20 times less when the allergen was carried by large particles (10.3 μm) than when Fel d 1 was carried by small particles (1.4 μm) [ 36 ]. However, a more recent article suggests that exposure under natural conditions to cat allergens (and not just to Fel d 1) induces a more peripheral airway obstruction [ 37 ].…”
BackgroundCats are the major source of indoor inhalant allergens after house dust mites. The global incidence of cat allergies is rising sharply, posing a major public health problem. Ten cat allergens have been identified. The major allergen responsible for symptoms is Fel d 1, a secretoglobin and not a lipocalin, making the cat a special case among mammals.Main bodyGiven its clinical predominance, it is essential to have a good knowledge of this allergenic fraction, including its basic structure, to understand the new exciting diagnostic and therapeutic applications currently in development. The recent arrival of the component-resolved diagnosis, which uses molecular allergens, represents a unique opportunity to improve our understanding of the disease. Recombinant Fel d 1 is now available for in vitro diagnosis by the anti-Fel d 1 specific IgE assay. The first part of the review will seek to describe the recent advances related to Fel d 1 in terms of positive diagnosis and assessment of disease severity. In daily practice, anti-Fel d 1 IgE tend to replace those directed against the overall extract but is this attitude justified? We will look at the most recent arguments to try to answer this question. In parallel, a second revolution is taking place thanks to molecular engineering, which has allowed the development of various forms of recombinant Fel d 1 and which seeks to modify the immunomodulatory properties of the molecule and thus the clinical history of the disease via various modalities of anti-Fel d 1-specific immunotherapy. We will endeavor to give a clear and practical overview of all these trends.
“…Indeed, whereas in the Boehlecke study the mass median aerodynamic diameter of endotoxin particles was 4.9 μm, we chose to nebulize particles with a medium mass aerodynamic diameter of 10 μm. Indeed, we have recently demonstrated that the levels of Fel d 1 that induced immediate bronchial response in asthmatic patients were 20 times lower when the allergen was carried by large particles [18]. According to preliminary data on airborne endotoxin measurements with cascade impactor in swineries, we also nebulized endotoxin on large particles.…”
Our study demonstrated that pre-exposure to LPS at low levels, which may be encountered in domestic environment, had no significant effect on the immediate and late-phase bronchial response to cat allergen. It neither modified local and systemic eosinophilic inflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.